​
Login / Signup
Yanbai Li
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 6
Top Topics
Clinical Trial
Transcription Factor
Coronavirus Disease
Phase Ii
Top Venues
mBio
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Yanbai Li
,
Shanshan Huo
,
Zhe Yin
,
Zuguang Tian
,
Fang Huang
,
Peng Liu
,
Yue Liu
,
Fei Yu
Retracted and republished from: "The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs".
mBio
(2024)
Yanbai Li
,
Shanshan Huo
,
Zhe Yin
,
Zuguang Tian
,
Fang Huang
,
Peng Liu
,
Yue Liu
,
Fei Yu
Retracted and republished from: "The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs".
mBio
15 (5) (2024)
Yanbai Li
,
Shanshan Huo
,
Zhe Yin
,
Zuguang Tian
,
Fang Huang
,
Peng Liu
,
Yue Liu
,
Fei Yu
Retracted and republished from: "The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs".
mBio
15 (5) (2024)
Yanbai Li
,
Shanshan Huo
,
Zhe Yin
,
Zuguang Tian
,
Fang Huang
,
Peng Liu
,
Yue Liu
,
Fei Yu
Retracted and republished from: "The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs".
mBio
15 (5) (2024)
Yanbai Li
,
Shanshan Huo
,
Zhe Yin
,
Zuguang Tian
,
Fang Huang
,
Peng Liu
,
Yue Liu
,
Fei Yu
Retracted and republished from: "The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs".
mBio
15 (5) (2024)
Yanbai Li
,
Shanshan Huo
,
Zhe Yin
,
Zuguang Tian
,
Fang Huang
,
Peng Liu
,
Yue Liu
,
Fei Yu
Retracted and republished from: "The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs".
mBio
15 (5) (2024)